General Archive
![](https://www.lifearc.org/wp-content/uploads/2024/01/image-1.png)
-
Articles & blogs
International Women’s Day 2023
Tips on career advancement, from some of LifeArc’s incredible women
-
News releases
The Aisling Burnand Daphne Jackson Research Fellowship, sponsored by LifeArc
The Board at LifeArc announces today it is sponsoring five Daphne Jackson Fellowships.
-
Articles & blogs
Honouring the contribution of a remarkable trustee – Aisling Burnand CBE
Melanie Lee pays tribute to Aisling Burnand and her immense contribution to the life sciences sector.
-
Articles & blogs
Rare Disease Day 2023 – Robbie’s story
Robbie has a rare genetic neurodegenerative disease known as AP-4 Hereditary Spastic Paraplegia (AP-4 HSP) subtype SPG47.
-
Articles & blogs
Four ways we support rare disease research
LifeArc provides a range of advice, funding and science to help scientists turn promising research into potential treatments.
-
Articles & blogs
LifeArc awards £3 million to advance promising early rare disease research from the lab to the patient
Pump-prime funding to help researchers get innovative approaches off the ground
-
Ventures funding, News releases
LifeArc Ventures invests in Maxion Therapeutics
Investment in Maxion Therapeutics to drive antibody development for previously untreatable ion channel and GPCR-driven diseases
-
Articles & blogs
Celebrating the International Day of Women and Girls in Science
LifeArc celebrates this year’s UN Day for Women and Girls in STEM.
-
Ventures funding, News releases
LifeArc Ventures – strong performance in 2022 & sustained investment in innovation
LifeArc Ventures, which is committed to investing in innovative early-stage life science companies, provides an update on its portfolio.
-
News releases
£1 million awarded to develop cutting-edge therapies for motor neuron disease
London, 24 January 2023: Medical research charity LifeArc, the Motor Neurone Disease Association (MND Association) and the My Name’5 Doddie…
-
News releases
LifeArc portfolio company RQ Bio’s antibody enters clinical trials
The first of RQ Bio’s discovered monoclonal antibodies to prevent COVID-19 in vulnerable patients has entered clinical trials.
-
Articles & blogs
Alzheimer’s drug lecanemab approved by US regulator
LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the…